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Abstract
Background—Preventing preterm birth and subsequent adverse neonatal sequelae is among the 
greatest clinical challenges of our time. Recent studies suggest a role for Candida spp. in preterm 
birth and fetal injury, as a result of their colonization of either the vagina and/or the amniotic 
cavity. We hypothesised that intraamniotic C. albicans would cause a vigorous, acute fetal 
inflammatory response.
Methods—Sheep carrying singleton pregnancies received single intraamniotic (IA) injections of 
either saline (control) or 107 CFU C. albicans 1 or 2 d prior to surgical delivery and euthanasia at 
124 ± 2 d gestation.
Results—Colonization of the amniotic cavity by C. albicans resulted in a modest inflammatory 
response at 1 d and florid inflammation at 2 d, characterised by fetal thrombocytopenia, 
lymphopenia and significant increases of inflammatory cytokines/chemokines in the fetal 
membranes skin, lung and the amniotic fluid.
Conclusion—Acute colonization of the amniotic cavity by C. albicans causes severe 
intrauterine inflammation and fetal injury. C. albicans is a potent fetal pathogen which can 
contribute to adverse pregnancy outcomes.
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Preterm birth remains a leading cause of neonatal mortality and morbidity worldwide. 
Although the causes of preterm birth are multi-factorial, infection of the amniotic cavity and 
subsequent intrauterine inflammation are both strongly associated with preterm delivery and 
adverse neonatal outcomes (including respiratory, gastrointestinal and neurological injuries), 
most notably in deliveries occurring at ≤ 32 weeks completed gestation 1–3. Culture and 
molecular-based analyses have identified bacterial genera including Ureaplasma, 
Fusobacterium, Streptococcus, Bacteroides and Gardnerella spp. as the microorganisms 
most commonly isolated from preterm deliveries 1,4,5. Recent studies suggest that many of 
the intrauterine infections associated with preterm labour are polymicrobial in nature 5,6.
Historically, the role of Candida spp. in preterm birth and neonatal injury has been 
somewhat unclear. However, recent molecular data suggest that Candida albicans may 
colonise the amniotic cavity more frequently than initially suggested by culture-based 
analyses, and cases of congenital candidiasis have been reported in the literature 7–12. Rode 
and colleagues have suggested a possible association between serial amniocenteses and 
candida chorioamnionitis 13. More recently, Bean et al. published the resolution of two cases 
of intraamniotic Candida albicans infection with maternal and intraamniotic fluconazole. 
Key conclusions of this case report were that intraamniotic Candida albicans infection has 
devastating implications for the fetus and that prompt diagnosis and treatment of infection is 
essential for pregnancy wellbeing 14.
Candida spp., (most commonly C. albicans) are believed to asymptomatically colonise the 
vagina of 20% of healthy women (more frequently during pregnancy), and invasive 
candidiasis can be a primary cause of death and neurological injury in extremely low birth-
weight infants (<1000 g) 5,15–17. Although a causal association for bacterial infection in 
early preterm labour is well established, the role of Candida spp. in uterine infection and 
preterm delivery is more controversial 5,16. A large multi-centre study of pregnancy 
outcomes and Candida spp. colonization in 13,914 women concluded that colonization with 
Candida spp. was not associated with low birth weight or preterm delivery 18. In direct 
contrast, a retrospective study of 38,151 infants, identified a 34–64% reduction in preterm 
birth in a subset (8.1%) born to mothers that received Clotrimazole (anti-Candida spp.) 
treatment during pregnancy 19. In addition, more recent smaller intervention studies reported 
either a significant reduction or a trend to reduction in preterm birth in groups receiving 
treatment for asymptomatic vaginal candidiasis 16,20. Of particular interest is research 
suggesting an apparent association between indwelling contraceptives and cervical cerclage 
with Candida spp. infection of the amniotic cavity 5.
We have previously utilised pregnant sheep to investigate the effects of E.coli 
lipopolysaccharides (LPS)21, antenatal corticosteroids 22, interleukin (IL)-1 23 and live 
Ureaplasma spp. 24 on the fetal lung 25, gut26 and skin27 and modulation of the fetal 
immune system 28. In light of emerging clinical data, animal studies are now needed to 
clarify the impact of acute intraamniotic C. albicans infection. To that end, we tested the 
pathogenicity of acute intrauterine C. albicans infection in a sheep model of human 
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All procedures involving animals were performed at The University of Western Australia 
(Perth, Western Australia) following review and approval by the animal care and use 
committees of The University of Western Australia and Cincinnati Children’s Hospital 
(Cincinnati, OH.). Twenty nine date-mated Australian merino ewes with singleton 
pregnancies were randomised to receive either: i) a single ultrasound-guided intraamniotic 
injection of 2 mL saline (n=13); or ii) a single ultrasound-guided intraamniotic injection of 
107 CFU C. albicans (Western Australian clinical isolate) in 2 mL saline with delivery after 
1 d (1 d Candida group; n=8) or 2 d (2 d Candida group; n=8). Successful placement of 
intraamniotic injections were confirmed with electrolyte (Cl−) analysis of amniotic fluid 
using a Siemens Rapidlab 1265 Analyser (Siemens, Munich, Germany). No fetal losses 
occurred in the 1 d Candida, 2 d Candida or Saline control groups.
Fetuses were surgically delivered at 124 ± 2 d GA, and euthanized with intravenous 
pentobarbitone (100 mg/kg). Fetal lung fluid and tissues for protein and mRNA expression 
analyses were collected at autopsy and snap frozen in liquid nitrogen. To eliminate a 
potential sampling bias, fetal skin was selectively collected from the fetal groins. A 
minimum of five, randomly selected animals were analysed from each group. Fetal lung 
tissues for histological analysis were inflation fixed in 10% neutral buffered formalin for 24 
h before paraffin embedding. Fetal skin tissues for histological analysis were cryopreserved 
in OCT.
Candida albicans culture for intraamniotic injection
A single Western Australian clinical isolate of C. albicans was cultured on Difco Sabaraud-
Dextrose agar (Becton Dickinson & Co., Franklin Lakes, NJ.) at 37°C for 48 h and single 
colonies were inoculated into sterile 1 × phosphate buffered saline (Sigma-Aldrich, St. 
Loius, MO.). C. albicans colony morphology was confirmed by growth on Brilliance 
Candida Agar (Oxoid). Inoculums were quantified using a plate dilution series as per 
standard microbiological methods and recorded as CFU/mL. Quantified inoculums (107 
CFU in 2 mL 1 × phosphate buffered saline) were stored at −80°C prior to use.
Nucleic acid extraction
To develop a standard curve for quantitation of C. albicans in fetal tissues, total RNA was 
extracted from 250 μL of C. albicans (the same Western Australian clinical isolate used in 
vivo in this study) using the Versant Sample Preparation kit 1.0 (Siemens, Munich, 
Germany) on a Kingfisher automated extraction platform (Thermo Scientific, Rockford, IL.) 
as per manufacturer’s instructions. Total RNA was extracted from liquid nitrogen-
homogenised fetal tissues using TRIzol as previously reported21. Extracted RNA was treated 
with Turbo-DNase (Life Technologies, Carlsbad, CA.) to remove any residual DNA and 
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subsequently quantified on a Qubit fluorometer (Life Technologies) using a broad-range 
RNA quantitation kit. RNA yields from fetal tissues were normalised to 100 ng/μL.
Candida albicans detection/quantitation
RNA extracted from fetal lung, skin, chorioamnion and spleen was screened using a real-
time PCR assay targeting the RNase P RNA gene of C. albicans 29. RNA-based reactions 
were performed using an EXPRESS One-Step SuperScript qRT-PCR Kit (Life 
Technologies) with 0.5 μM each primer, 0.2 μM probe, 400 ng template RNA and water to a 
final volume of 20 μL. To enable quantitation of C. albicans within each sample, a standard 
curve of pure C. albicans (study isolate) RNA was included in each assay at a final 
concentration of 40, 4 and 0.4 ng per 20 uL reaction. Reaction cycling conditions were as 
follows: 15 min reverse transcription at 50°C and an initial denaturation at 95°C for 20 s, 
followed by 40 cycles of 95°C for 3 s and 60°C for 30 s. All reactions were performed in 96 
well plates on a ViiA7 real-time PCR thermocycler (Life Technologies). The presence of 
viable C. albicans in amniotic fluid samples was determined using a Sabaraud-Dextrose agar 
plate dilution series as described above. Three single colonies from positive plates were 
subsequently inoculated onto Candida Brilliance agar (Oxoid, Basingstoke, UK) for 
confirmation of isolate identification.
Relative quantification of mRNA expression
Ovine-specific PCR primers and hydrolysis probes for IL-1β, IL-6, IL-8, TNF-α, MCP-1 
and MCP-2 (Life Technologies) were used to perform quantitative PCR reactions on RNA 
from fetal lung, skin, and chorioamnion tissue. Reactions were performed using an 
EXPRESS One-Step SuperScript qRT-PCR Kit (Life Technologies) with 400 ng template 
RNA in a total volume of 20 μL. Reaction cycling conditions were as described above. Cq 
values were normalised to 18s rRNA and expressed as fold changes relative to pooled 
control values. Reaction efficiencies were within limits proposed in the MIQE guidelines 30.
Enzyme-linked immunosorbent assays
Quantification of IL-1β and IL-8 protein concentrations in AF was performed as previously 
described 31. AF samples were diluted 1:5 in assay buffer. Quantification of IL-6 protein 
concentration in ovine AF was performed using an identical protocol with the following 
modifications: Plate wells were coated overnight at 4°C with 5 μg/mL capture antibody 
(MCA1659; ABD Serotech, Kidlington, UK). Recombinant sheep IL-6 protein standards 
(Protein Express, Cincinnati, OH.) and AF samples, diluted 1:2 in assay buffer, were 
incubated overnight at 4°C. The detection antibody (AHP424; ABD Serotech) was diluted 
1:750 in assay buffer. All samples and standards were assayed in duplicate. Cortisol 
measurements were performed with a Cortisol EIA kit (Oxford Biomedical Research, 
Rochester Hills, MI.) on 1:10 diluted fetal arterial cord blood plasma according to the 
manufacturer’s instructions.
Haematology
Complete blood counts (CBC) and differential analyses were performed with an automated 
Coulter counter customised for sheep blood.
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5 μm-thick sections from formalin fixed lung (right upper lobe) tissues embedded in paraffin 
blocks or 10 μm-thick sections from cryopreserved skin tissues embedded in OCT were 
stained with haematoxylin and eosin. For lung tissues, five random fields were scored for 
inflammatory cell infiltration and airway consolidation as follows: 0: Normal; 1: Airway 
inflammatory cells, no consolidation; 2: Airway inflammatory cells + microconsolidation 
focii (1–2/5 Low Power Field); 3: Airway inflammatory cells + microconsolidation focii 
(≥3/5 Low Power Field); and 4: Extensive airway inflammatory cells and consolidation. 
Immunohistochemical staining of fetal lung for CD3 (A0452, Dako, Glostrup, Denmark, 
working concentration 1:100) and C. albicans (B65411R, Meridian Life Science, Inc. 
Memphis, TN., working concentration 1:50) was performed as previously published32. CD3 
counts in fetal lung were obtained by counting positively stained cells in five randomly 
selected, non-overlapping fields at 20 × objective magnification.
Statistical analyses
All values are expressed as mean ± standard deviation (SD). All analyses were performed 
using IBM SPSS Statistics for Windows, software version 20.0 (IBM Corp. Armonk, NY.). 
Data were assessed for normality with Shapiro-Wilk tests and histograms. Parametric data 
were screened for outliers with Dixon’s Q-parameter and differences tested for significance 
with one-way ANOVA employing an α-value of 0.05. Multiple post-hoc comparisons were 
performed using Tukey’s test. Apparent differences in non-parametric data were tested for 
significance with Kruskal-Wallis one-way ANOVA employing an α-value of 0.05. Multiple 
post-hoc comparisons were performed using Rank Sum Tests with an α-value corrected for 
n multiple comparisons.
Results
Intrauterine infection with 107 CFU C. albicans resulted in florid intrauterine inflammation 
at 2 d post-infection. Limited histological changes in skin and lung, and relatively modest 
increases in cytokine/chemokine expression were detected in fetal tissues collected 1 d post-
infection.
Detection of viable Candida albicans
Amniotic fluid from all 1 d and 2 d C. albicans exposed animals but none of the controls 
were positive for viable C. albicans growth (data not shown). qPCR analysis demonstrated 
increased C. albicans RNA in fetal lung (3.8 ± 3 ng), chorioamnion (78 ± 32 ng) and skin 
(50 ± 48 ng) taken from animals exposed to C. albicans for 2 d, relative to fetal lung (0.2 ng 
± 0.1 ng), chorioamnion (14 ± 10 ng) and skin (6.0 ± 5.0 ng) exposed to C. albicans for 1 d 
(Figure 1a). The highest levels of C. albicans RNA were detected in chorioamnion tissue 
after a 2 d exposure (p < 0.010 vs. 2 d fetal lung). No C. albicans RNA was detected in the 
fetal spleen after either 1 d or 2 d C. albicans exposure or in any saline control animal.
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Cytokine/chemokine protein concentration in fetal plasma, amniotic fluid and fetal lung 
fluid
No changes in IL-1β, IL-6 or IL-8 protein concentration were detected in fetal plasma from 
animals exposed to C. albicans for either 1 d or 2 d, relative to control (data not shown). 
Analysis of IL-1β, IL-6 and IL-8 protein concentrations in the AF demonstrated significant 
increases in the concentration of: i) IL-1β in 2 d C.albicans exposed animals relative to 1 d 
C. albicans exposed animals (p=0.001) and control (p=0.002); and ii) IL-8 in 2 d C. albicans 
exposed animals relative to 1 d C. albicans exposed animals (p=0.044) and control 
(p=0.046). No change in IL-6 concentration was detected (Figure 1b). Analysis of IL-1β, 
IL-6 and IL-8 protein concentration in fetal lung fluid demonstrated significant increases in 
the concentration of: i) IL-1β in 2 d C. albicans exposed animals relative to control (680 ± 
900 pg/mL vs. 157 ± 10 pg/mL; p=0.048); and ii) IL-8 in 2 d C. albicans exposed animals, 
relative to control (20 ± 18.5 ng/mL vs. 1.4 ± 2.0 ng/mL p=0.002). No change in fetal lung 
fluid IL-6 concentration was detected (data not shown).
Elevated circulating fetal cortisol
Concentrations of cortisol in fetal arterial plasma demonstrated variable, but significant 
increases in concentration at 2 d post-infection relative to 1 d post-infection (p=0.007) and 
control (p=0.002) (Figure 2).
Haematological analyses
Complete/differential fetal blood counts demonstrated marked thrombocytopenia and 
leukopenia after 2 d intrauterine C. albicans infection (Table 1); circulating platelets 
(p=0.026) and white blood cells (p=0.006) were significantly reduced relative to control. 
Lymphocytes at 2 d post-infection were significantly reduced relative to counts at 1 d post-
infection (p=0.015) and an apparent reduction relative to control counts closely approached 
significance (p=0.08).
Elevated cytokine/chemokine mRNA expression in the fetal lung, skin and membranes
Analysis of cytokine/chemokine expression in the fetal lung, skin and membranes identified 
a pattern of significant mRNA up-regulation at 2 d post-C. albicans infection, relative to 
both control and 1 d post-C. albicans infection tissues. Significant increases in IL-1β 
(p=0.007), IL-6 (p=0.007), IL-8 (p=0.010), TNF-α (p=0.003) and MCP-1 (p=0.003) mRNA 
expression were identified in the fetal lung at 2 d post-infection, relative to control (Figure 
3a). In the fetal skin, significant mRNA increases were observed in the expression of IL-6 at 
2 d (p=0.004), TNF-α at 2 d (p=0.019), IL-8 at 1 d (p=0.000) and 2 d (p=0.000), and MCP-2 
at 1 d (p=0.031) and 2 d (p=0.000) post-C. albicans infection, relative to control (Figure 3b). 
In fetal membranes, a significant increase was only observed in IL-8 mRNA expression 
(p=0.020) at 2 d post-C. albicans infection, relative to control (Figure 3c).
Histological analysis of the fetal lung and skin
Seven of eight fetal lung samples from the 2 d Candida group assessed for inflammation and 
consolidation were graded 2 (n=4) or 3 (n=3) (Figure 4a), consistent with robust 
inflammation of the fetal lung. A marked increase in C. albicans staining intensity and 
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distribution was apparent in lung tissues taken from 2 d C. albicans-exposed animals, 
relative to 1 d C. albicans-exposed and saline control animals (Figure 4a insert). CD3-
positive cells were significantly increased (33.0 ± 8.0 vs. 12.0 ± 4.0 cells/low power field, 
p=0.006) in the fetal lung of animals exposed to C. albicans for 2 d, relative to control 
(Figure 4b). Haemotoxylin and eosin staining of transverse fetal skin sections demonstrated 
numerous foci of basophilic infiltration of the stratum corneum at 2 d post-infection (Figure 
5a). Immunofluorescent analysis of IL-8 expression in the fetal skin demonstrated distinct 
increases in signal intensity and distribution in 1 d and 2 d C. albicans exposed tissues, 
relative to control (Figure 5b).
Discussion
Comparatively little animal data are available to describe the inflammatory response to acute 
C. albicans colonization of the amniotic cavity 33–35. We present novel data demonstrating: 
i) the colonization of the amniotic environment by C. albicans following intra-amniotic 
infection; and ii) that intrauterine infection with C.albicans rapidly progresses to an active 
infection involving multiple fetal surfaces yielding florid intrauterine inflammation and 
depletion of circulating fetal immunocytes and platelets. These findings add weight to recent 
clinical reports concluding that the prompt diagnosis and treatment of intraamniotic C. 
albicans infection is critical to pregnancy wellbeing 14.
Infection of the amniotic cavity with C. albicans was characterised by a quasi-latent period 
of at least 1 d post-infection. Although significant increases in IL-6, IL-8 and MCP-2 
mRNA transcript expression were identified in the fetal skin and IL-8 protein concentration 
in the AF at 1 d post-infection, no changes were identified in lung or chorioamnion mRNA 
expression, fetal arterial plasma cortisol levels or fetal white blood cell counts. At 2 d post-
infection, significant increases in mRNA expression were detected in the fetal skin and lung, 
with a limited (IL-8 only) response detected in the chorioamnion.
Cytokine/chemokine mRNA expression in the fetal skin and lung, and cytokine protein 
concentrations in the fetal lung fluid correlated with increased C. albicans RNA levels at 2 
d. Interestingly, the vigorous inflammatory response identified in the fetal lung in the 2d 
post-infection group was disproportionate to the comparatively low level of C. albicans 
RNA detected. Conversely, the inflammatory response detected in the chorioamnion was 
comparatively mild (given the high levels of C. albicans RNA isolated from this tissue) at 
both 1 d and 2 d. These data suggest a differential sensitivity between tissues (lung, skin and 
chorioamnion) to inflammatory stimulation by C. albicans. Surprisingly, no C. albicans 
RNA was detected in the fetal spleen in either the 1 d or 2 d post-infection groups. Although 
we did not extensively culture from aseptically harvested fetal organs, these molecular data 
indicate that C. albicans does not gain access to the fetal circulation by 2 d despite 
significant colonization of the fetal lung and skin. This observation also suggests that the 
systemic changes (alterations in leukocyte counts and fetal arterial plasma) identified in this 
study are due to inflammatory signalling derived from amniotic fluid-exposed skin/amnion 
and lung. Using chronically instrumented preterm lambs, we have previously demonstrated 
the importance of the fetal lung to acute systemic inflammation32. Those findings are 
supported by data in the present study, which also suggest that fetal lung inflammation is a 
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key mediator of a systemic fetal response. Additionally, our data also suggest that 
inflammation of the fetal skin/chorioamnion, in the absence of fetal lung inflammation, is 
sufficient to increase cytokine (IL-8) concentrations in the AF. Although not investigated in 
the present study, it would be of great interest to assess the inflammatory and structural 
changes deriving from colonization of the fourth AF-exposed fetal surface, the gastro-
intestinal tract, by C. albicans.
Our data also contrast with earlier LPS-based studies in this model, wherein intraamniotic 
injection of 10 mg LPS resulted in broad increases in mRNA expression in both the fetal 
lung and chorioamnion at 1 d post-injection36. The isolation of fetal inflammatory response 
to the skin at 1 d post C. albicans infection may derive from the complete exposure of the 
fetal skin to the AF and C. albicans’ preference this epithelial surface 37. It may also reflect 
a temporal difference in inflammatory response between skin and chorioamnion in the 
sheep . Interestingly, the magnitude and scope of inflammatory response elicited by 2 d 
infection with C. albicans was much greater than that identified in previous studies in fetal 
sheep involving E. coli lipopolysaccharides or Ureaplasma spp. over a similar time 
frame 27,38,39.
The marked increase in fetal cortisol identified in the 2 d post-infection group is consistent 
with a robust fetal inflammatory response 40 and is similar in relative size to that 
demonstrated by Challis and colleagues in chronically catheterised fetal sheep immediately 
prior to parturition41; chorioamnionitis and elevated levels of IL-1β and IL-6 have also been 
demonstrated to increase fetal cortisol production, inducing fetal lung maturation and 
reduced birth weight 40,42.
Thrombocytopenia is a salient feature of congenital and neonatal candidiasis 43,44; an 
especially striking feature of 2 d C. albicans infection in the present study was a marked 
reduction in fetal platelets. In contrast to our 2 d findings, however, congenital candidiasis is 
associated with a marked increase in total white blood cells 8,9,45. This difference may relate 
to species or gestation-dependent responses to C. albicans infection or be a function of the 
acute (2 d) nature of our experimental model.
Limitations of this study include the acute time frame over which the impact of C. albicans 
infection was assessed and that the infection was established by intraamniotic injection as 
opposed to ascending vaginal infection and penetration of the fetal membranes, the 
hypothesised route of the majority of intrauterine infection in humans 2. Further studies, 
potentially employing a low-titre inoculum and sub-chorionic infection to mimic ascending 
infection via a focal breach in the fetal membranes 46, are warranted to advance our 
understanding of the pathogenic role played by C. albicans in pregnancy.
Conclusions
An increasing number of clinical studies now suggest a role for Candida spp. in preterm 
birth and fetal injury. Our data support the recently published findings of Bean and 
colleagues 14 and further suggest a likely role for C. albicans in preterm birth and 
chorioamnionitis. Importantly, our data demonstrate that an untreated acute infection of the 
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amniotic cavity with C. albicans can cause a devastating, florid fetal inflammatory response 
that is consistent with adverse neonatal outcomes. Additional animal and clinical studies are 
warranted to further assess the role of Candida spp. in preterm birth and fetal injury, the 
potential benefits of Candida spp. screening and the best means of administering 
prophylaxis and treatment in pregnancy.
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Panel A: C. albicans RNA in fetal tissues in 1 d and 2 d post-infection groups. (1 d Candida 
n=5; 2 d Candida n=5). CHR, chorioamnion; SK, skin; RLL, right lower lobe of lung. *, 
significant difference (p < 0.010) vs. RUL. Panel B: Concentration of IL-1β (Black bars, 
Control n=10; Grey bars, 1 d Candida n=8; Hatched bars, 2 d Candida n=8) and IL-8 (Black 
bars, Control n=6; Grey bars, 1 d Candida n=6; Hatched bars, 2 d Candida n=6), but not 
IL-6 (Black bars, Control n=6; Grey bars, 1 d Candida n=6; Hatched bars, 2 d Candida n=6;) 
is increased in AF in response to IAI with C. albicans. * p<0.05 vs. control; † p<0.05 vs. 1 d 
Candida albicans exposure.
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Concentration of fetal arterial plasma cortisol (Control n=13; 1 d Candida n=8; 2 d Candida 
n=8) is increased in response to 2 d C. albicans exposure, vs. control. * p<0.05 vs. control; † 
p<0.05 vs. 1 d C. albicans exposure.
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Panel A: Expression of cytokine/chemokine mRNA is increased in the fetal lung in 
response to 2 d C. albicans exposure. Black bars, Control n=13; Grey bars, 1 d Candida n=8; 
Hatched bars, 2 d Candida n=8. * p<0.05 vs. control; † p<0.05 vs. 1 d C. albicans exposure. 
Panel B: Expression of cytokine/chemokine mRNA is variably increased in the fetal skin in 
response to 1 d and 2 d C. albicans exposure. Black bars, control n=6; Grey bars, 1 d 
Candida n=5; Hatched bars, 2 d Candida n=6. * p<0.05 vs. control; † p<0.05 vs. 1 d C. 
albicans exposure. Panel C: Only IL-8 is significantly increased in the chorioamnion in 
response to 1 d and 2 d C. albicans exposure. Black bars, Control n=6; Grey bars, 1 d 
Candida n=6; Hatched bars, 2 d Candida n=5) * p<0.05 vs. control.
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Infiltration and consolidation of the fetal lung in response to 2 d C. albicans exposure 
(Control n=13; 1 d Candida n=8; 2 d Candida n=8). Panel A: Control; Panel B: 1 d C. 
albicans exposure; and Panel C: 2 d C. albicans exposure. Inserts: Immunofluorescent 
staining for cell nuclei (DAPI; blue) and C. albicans (Alexa 594; red). All scale bars 
represent 50 μm. Panel D: Analysis of Infiltration of fetal lung by CD3-positive cells in 
response to colonization with C. albicans. (Control n=6; 1 d Candida n=5; 2 d Candida n=5) 
* p<0.05 vs. control. HPV, high power view.
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Panel A: Infiltration of the fetal skin in response to C. albicans exposure. (Control n=5; 1 d 
Candida n=5; 2 d Candida n=5). i: Control; ii: 1 d C. albicans exposure; and iii: 2 d C. 
albicans exposure. Scale bar represents 50 μm. Panel B: Relative to control, 
immunofluorescent staining for IL-8 (Alexa 488; green) is increased in the fetal dermis and 
epidermis after 1 d and 2 d C. albicans exposure. i: Control n=5 ii: 1 d Candida n=5; iii: 2 d 
Candida n=5. Cell nuclei are stained blue with DAPI. Scale bar represents 200 μm.
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